Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros

Métodos Terapêuticos e Terapias MTCI
Base de dados
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Int J Urol ; 16(4): 420-3, 2009 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-19416405

RESUMO

We developed a local anesthetic procedure for three-dimensional 26-core prostate biopsy (3D26PBx), a combination of transperineal 14-core biopsy (TP14PBx) and transrectal 12-core biopsy (TR12PBx). At first, a periapical triangle, confined by the levator ani, the rhabdosphincter and the external anal sphincter muscle, was made visible by transrectal ultrasound. After administration of 1 mL of 1%-lidocaine into the midline perineal skin 1.5 cm above the anus, we inserted a spinal needle toward the periapical triangle for injection of 1.5-2.0 mL of 1%-lidocaine and performed the TP14PBx. After administration of the periprostatic nerve block with 10 mL of 1%-lidocaine, we performed the TR12PBx. The efficacy of the procedure was evaluated prospectively in 45 consecutive men undergoing the 3D26PBx. The 3D26PBx was completed with just local anesthesia in all patients. The pain levels, assessed by an 11-point visual analog scale, were not different between the TP14PBx and the TR12PBx.


Assuntos
Anestesia Local/métodos , Próstata/patologia , Biópsia por Agulha/métodos , Humanos , Masculino , Períneo
2.
Int J Urol ; 11(7): 501-9, 2004 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-15242359

RESUMO

AIM: The aim of our study was to examine the efficacy of naftopidil in terms of the international prostate symptom score (IPSS) and urodynamic parameters in the treatment of benign prostatic hyperplasia (BPH). Eviprostat was used as a control to study the efficacy of naftopidil. METHODS: Forty-nine patients with BPH (mean age 67.9 +/- 7.8 years) were involved in the study. Patients were randomly assigned either to the naftopidil group, which was treated with the alpha-blocker naftopidil (50-75 mg daily, 36 patients), or the eviprostat group, which was treated with phytotherapy (six tablets of eviprostat daily, 13 patients). RESULTS: The mean total IPSS, the total storage and voiding symptom scores, and the quality of life score decreased significantly (P < 0.0001 for each variable) in the naftopidil group, but not in the eviprostat group. In the naftopidil group, analyses showed significant increases in average and maximum flow rate and bladder capacity at first desire to void (P < 0.001, P = 0.001 and P = 0.024, respectively), and significant decreases in the postvoid residual, the percent of residual and the Abrams-Griffiths number (P = 0.009, P = 0.008 and P = 0.042, respectively). However, in the eviprostat group, no significant changes were noted in terms of these symptomatic and urodynamic parameters. In the pressure/flow study, an improvement in the International Continence Society nomogram grade was noted in 29% of the naftopidil group, but in only 16% of the eviprostat group. Among the 14 patients in the naftopidil group, detrusor overactivity disappeared in 21% and cystometric capacity increased in 36%, but no improvement in detrusor overactivity was noted in the eviprostat group. CONCLUSIONS: Naftopidil appears to have been effective in this short-term treatment of BPH.


Assuntos
Antagonistas Adrenérgicos alfa/uso terapêutico , Etamsilato/uso terapêutico , Naftalenos/uso terapêutico , Fitoterapia , Piperazinas/uso terapêutico , Extratos Vegetais/uso terapêutico , Preparações de Plantas/uso terapêutico , Hiperplasia Prostática/tratamento farmacológico , Hiperplasia Prostática/fisiopatologia , Urodinâmica/efeitos dos fármacos , Idoso , Combinação de Medicamentos , Humanos , Masculino , Método Simples-Cego
3.
J Urol ; 172(1): 360-4, 2004 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-15201811

RESUMO

PURPOSE: We investigated the possible role of the endogenous nitric oxide (NO) synthase (NOS) inhibitors N-monomethyl-L-arginine (L-NMMA) and asymmetrical N, N-dimethyl-L-arginine (ADMA) in inhibiting urethral relaxation following estrogen supplementation in ovariectomized rabbits. MATERIALS AND METHODS: A total of 16 mature Japanese White female rabbits were divided into 2 groups. In the control group rabbits were sacrificed 2 weeks after bilateral ovariectomy. In the estrogen group estradiol was administered subcutaneously for 2 weeks with the aid of sustained release pellet from 2 weeks after ovariectomy until sacrifice. Isolated urethra was cut into transverse strips for functional study and processed to determine endogenous NOS inhibitors, NOS activity, dimethylarginine dimethylaminohydrolase (DDAH) activity as a metabolizing enzyme of endogenous NOS inhibitors and cyclic guanosine monophosphate production. RESULTS: Electrical field stimulation produced NO mediated and neurogenic relaxation of the urethral strip in the presence of guanethidine and atropine under contraction with phenylephrine. Relaxation was significantly decreased in the estrogen group and accompanied by decreased cyclic guanosine monophosphate production. Sodium nitroprusside induced relaxation was not different between the 2 groups. The content of L-NMMA plus ADMA in the urethra was significantly increased in the estrogen group. Ca dependent NOS activity in the urethra remained unaffected. DDAH activity was significantly lower in the estrogen group. CONCLUSIONS: Estrogen supplementation leads to decreased NO mediated and neurogenic urethral relaxation through the accumulation of L-NMMA and ADMA in the urethra. The accumulation of NOS inhibitors is possibly brought about by impaired DDAH activity.


Assuntos
Estradiol/farmacologia , Óxido Nítrico Sintase/antagonistas & inibidores , Uretra/efeitos dos fármacos , ômega-N-Metilarginina/fisiologia , Amidoidrolases/metabolismo , Animais , Peso Corporal , GMP Cíclico/análise , Preparações de Ação Retardada , Estimulação Elétrica , Estradiol/administração & dosagem , Feminino , Técnicas In Vitro , Contração Muscular/efeitos dos fármacos , Contração Muscular/fisiologia , Tamanho do Órgão , Ovariectomia , Coelhos , Radioimunoensaio , Tela Subcutânea , Uretra/enzimologia
4.
Am J Physiol Regul Integr Comp Physiol ; 282(6): R1730-8, 2002 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-12010755

RESUMO

We examined whether endogenous inhibitors of nitric oxide (NO) synthesis are involved in the impaired cavernosal relaxation with ischemia in rabbits. Two weeks after cavernosal ischemia caused by partial vessel occlusion, endothelium-dependent and electrical field stimulation (EFS)-induced neurogenic NO-mediated relaxations, but not sodium nitroprusside (SNP)-induced relaxation, were significantly impaired in the isolated corpus cavernosum. The Ca(2+)-dependent NO synthase (NOS) activity and the basal and stimulated cGMP productions with carbachol or EFS were significantly decreased after ischemia. Supplementation of excess L-arginine partially recovered both of the impaired relaxations. The contents of N(G)-monomethyl-L-arginine (L-NMMA) and asymmetric N(G), N(G)-dimethyl-L-arginine (ADMA) but not L-arginine and symmetric N(G),N'(G)-dimethyl-L-arginine (SDMA) were increased in the cavernosal tissues after ischemia. Authentic L-NMMA and ADMA but not SDMA concentration dependently inhibited both relaxations without affecting the relaxation produced by SNP in the control. Excess L-arginine abolished the inhibition with L-NMMA and ADMA. These results suggest that the impaired NO-mediated cavernosal relaxations after ischemia are closely related to the decreased NOS activity and the increased accumulation of L-NMMA and ADMA.


Assuntos
Arginina/análogos & derivados , Inibidores Enzimáticos/farmacologia , Impotência Vasculogênica/tratamento farmacológico , Impotência Vasculogênica/fisiopatologia , Isquemia/fisiopatologia , Óxido Nítrico Sintase/antagonistas & inibidores , Pênis/fisiopatologia , Animais , Arginina/metabolismo , Arginina/farmacologia , Cálcio/metabolismo , Carbacol/farmacologia , Agonistas Colinérgicos/farmacologia , GMP Cíclico/biossíntese , Modelos Animais de Doenças , Relação Dose-Resposta a Droga , Estimulação Elétrica , Endotélio Vascular/efeitos dos fármacos , Endotélio Vascular/metabolismo , Artéria Ilíaca/fisiopatologia , Impotência Vasculogênica/etiologia , Técnicas In Vitro , Isquemia/complicações , Masculino , Óxido Nítrico Sintase/metabolismo , Pênis/irrigação sanguínea , Pênis/efeitos dos fármacos , Coelhos , Vasoconstritores/farmacologia , Vasodilatadores/farmacologia , ômega-N-Metilarginina/metabolismo , ômega-N-Metilarginina/farmacologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA